USANA HEALTH SCIENCES, INC. Selling, General and Administrative Expense
USANA HEALTH SCIENCES, INC. (USNA) reported Selling, General and Administrative Expense of $82.32 million for the 3-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-07-04 was $82.32M, a 0.50% increase year-over-year.
- USANA HEALTH SCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-04-04 was $88.25M, a 3.48% decline year-over-year.
- USANA HEALTH SCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-01-03 was $78.08M, a 6.45% increase year-over-year.
- USANA HEALTH SCIENCES, INC. selling, general and administrative expense for the quarter ending 2025-09-27 was $85.95M, a 40.22% increase year-over-year.
- USANA HEALTH SCIENCES, INC. selling, general and administrative expense for fiscal 2026 was $337.37M, a 28.15% increase from fiscal 2024.
- USANA HEALTH SCIENCES, INC. selling, general and administrative expense for fiscal 2024 was $263.27M, a 2.44% increase from fiscal 2023.
- USANA HEALTH SCIENCES, INC. selling, general and administrative expense for fiscal 2023 was $256.99M, a 2.03% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. selling, general and administrative expense for fiscal 2022 was $262.30M, a 6.02% decline from fiscal 2022.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-07-04 | $82.32M 10-Q · filed 2026-08-13 | $170.57M 10-Q · filed 2026-08-13 | $248.65M derived: sum of 3 quarters · filed 2026-08-13 | $334.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | $88.25M 10-Q · filed 2026-05-12 | $166.34M derived: sum of 2 quarters · filed 2026-05-12 | $252.28M derived: sum of 3 quarters · filed 2026-05-12 | $334.19M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $78.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $164.03M derived: sum of 2 quarters · filed 2026-03-16 | $245.93M derived: sum of 3 quarters · filed 2026-08-13 | $337.37M 10-K · filed 2026-03-16 |
| 2025-09-27 | $85.95M 10-Q · filed 2025-11-05 | $167.85M derived: sum of 2 quarters · filed 2026-08-13 | $259.29M 10-Q · filed 2025-11-05 | $332.64M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $81.91M 10-Q · filed 2026-08-13 | $173.34M 10-Q · filed 2026-08-13 | $246.69M derived: sum of 3 quarters · filed 2026-08-13 | $307.99M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | $91.44M 10-Q · filed 2026-05-12 | $164.79M derived: sum of 2 quarters · filed 2026-05-12 | $226.08M derived: sum of 3 quarters · filed 2026-05-12 | $290.41M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $73.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $134.64M derived: sum of 2 quarters · filed 2026-03-16 | $198.97M derived: sum of 3 quarters · filed 2026-03-16 | $263.27M 10-K · filed 2026-03-16 |
| 2024-09-28 | $61.30M 10-Q · filed 2025-11-05 | $125.62M derived: sum of 2 quarters · filed 2025-11-05 | $189.92M 10-Q · filed 2025-11-05 | $248.58M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-29 | $64.33M 10-Q · filed 2025-08-05 | $128.63M 10-Q · filed 2025-08-05 | $187.29M derived: sum of 3 quarters · filed 2026-03-16 | $250.59M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-30 | $64.30M 10-Q · filed 2025-05-06 | $122.96M derived: sum of 2 quarters · filed 2026-03-16 | $186.27M derived: sum of 3 quarters · filed 2026-03-16 | $254.36M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-30 | $58.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $121.97M derived: sum of 2 quarters · filed 2026-03-16 | $190.06M derived: sum of 3 quarters · filed 2026-03-16 | $256.99M 10-K · filed 2026-03-16 |
| 2023-09-30 | $63.30M 10-Q · filed 2024-11-05 | $131.40M derived: sum of 2 quarters · filed 2024-11-05 | $198.32M 10-Q · filed 2024-11-05 | $259.43M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-07-01 | $68.10M 10-Q · filed 2024-08-06 | $135.02M 10-Q · filed 2024-08-06 | $196.12M derived: sum of 3 quarters · filed 2025-03-12 | $262.14M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-04-01 | $66.93M 10-Q · filed 2024-05-07 | $128.03M derived: sum of 2 quarters · filed 2025-03-12 | $194.05M derived: sum of 3 quarters · filed 2025-03-12 | $260.43M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $61.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $127.12M derived: sum of 2 quarters · filed 2025-03-12 | $193.51M derived: sum of 3 quarters · filed 2025-03-12 | $262.30M 10-K · filed 2025-03-12 |
| 2022-10-01 | $66.02M 10-Q · filed 2023-11-07 | $132.41M derived: sum of 2 quarters · filed 2023-11-07 | $201.20M 10-Q · filed 2023-11-07 | $269.79M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $66.39M 10-Q · filed 2023-08-08 | $135.18M 10-Q · filed 2023-08-08 | $203.77M derived: sum of 3 quarters · filed 2024-02-27 | $270.42M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $68.80M 10-Q · filed 2023-05-09 | $137.39M derived: sum of 2 quarters · filed 2024-02-27 | $204.03M derived: sum of 3 quarters · filed 2024-02-27 | $276.27M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $68.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $135.23M derived: sum of 2 quarters · filed 2024-02-27 | $207.47M derived: sum of 3 quarters · filed 2024-02-27 | $279.11M 10-K · filed 2024-02-27 |
| 2021-10-02 | $66.64M 10-Q · filed 2022-11-08 | $138.88M derived: sum of 2 quarters · filed 2022-11-08 | $210.52M 10-Q · filed 2022-11-08 | $279.69M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $72.24M 10-Q · filed 2022-08-09 | $143.87M 10-Q · filed 2022-08-09 | $213.04M derived: sum of 3 quarters · filed 2023-02-28 | $278.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $71.63M 10-Q · filed 2022-05-11 | $140.81M derived: sum of 2 quarters · filed 2023-02-28 | $206.46M derived: sum of 3 quarters · filed 2023-02-28 | $267.34M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-01-02 | $69.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $134.83M derived: sum of 2 quarters · filed 2023-02-28 | $195.71M derived: sum of 3 quarters · filed 2023-02-28 | $261.19M 10-K · filed 2023-02-28 |
| 2020-09-26 | $65.66M 10-Q · filed 2021-11-10 | $126.53M derived: sum of 2 quarters · filed 2021-11-10 | $192.01M 10-Q · filed 2021-11-10 | $257.07M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $60.88M 10-Q · filed 2021-08-11 | $126.36M 10-Q · filed 2021-08-11 | $191.42M derived: sum of 3 quarters · filed 2022-03-01 | $257.68M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $65.48M 10-Q · filed 2021-05-11 | $130.54M derived: sum of 2 quarters · filed 2022-03-01 | $196.80M derived: sum of 3 quarters · filed 2022-03-01 | $263.65M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-28 | $65.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $131.32M derived: sum of 2 quarters · filed 2022-03-01 | $198.18M derived: sum of 3 quarters · filed 2022-03-01 | $267.73M 10-K · filed 2022-03-01 |
| 2019-09-28 | $66.26M 10-Q · filed 2020-11-03 | $133.12M derived: sum of 2 quarters · filed 2020-11-03 | $202.67M 10-Q · filed 2020-11-03 | $270.95M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-29 | $66.85M 10-Q · filed 2020-08-04 | $136.41M 10-Q · filed 2020-08-04 | $204.69M derived: sum of 3 quarters · filed 2021-03-02 | $273.80M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-30 | $69.56M 10-Q · filed 2020-05-05 | $137.83M derived: sum of 2 quarters · filed 2021-03-02 | $206.94M derived: sum of 3 quarters · filed 2021-03-02 | $274.48M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-29 | $68.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $137.39M derived: sum of 2 quarters · filed 2021-03-02 | $204.93M derived: sum of 3 quarters · filed 2021-03-02 | $275.06M 10-K · filed 2021-03-02 |
| 2018-09-29 | $69.11M 10-Q · filed 2019-11-05 | $136.65M derived: sum of 2 quarters · filed 2019-11-05 | $206.78M 10-Q · filed 2019-11-05 | $278.22M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $67.54M 10-Q · filed 2019-08-06 | $137.67M 10-Q · filed 2019-08-06 | $209.11M derived: sum of 3 quarters · filed 2020-02-25 | $276.37M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $70.13M 10-Q · filed 2019-05-07 | $141.57M derived: sum of 2 quarters · filed 2020-02-25 | $208.84M derived: sum of 3 quarters · filed 2020-02-25 | $271.23M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-30 | $71.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $138.70M derived: sum of 2 quarters · filed 2020-02-25 | $201.09M derived: sum of 3 quarters · filed 2020-02-25 | $265.09M 10-K · filed 2020-02-25 |
| 2017-09-30 | $67.26M 10-Q · filed 2018-11-07 | $129.65M derived: sum of 2 quarters · filed 2018-11-07 | $193.65M 10-Q · filed 2018-11-07 | $250.86M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-07-01 | $62.39M 10-Q · filed 2018-08-08 | $126.39M 10-Q · filed 2018-08-08 | $183.60M derived: sum of 3 quarters · filed 2019-02-26 | $244.19M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-04-01 | $64.00M 10-Q · filed 2018-05-09 | $121.21M derived: sum of 2 quarters · filed 2019-02-26 | $181.80M derived: sum of 3 quarters · filed 2019-02-26 | $241.56M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $57.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $117.80M derived: sum of 2 quarters · filed 2019-02-26 | $177.56M derived: sum of 3 quarters · filed 2019-02-26 | $234.19M 10-K · filed 2019-02-26 |
| 2016-10-01 | $60.59M 10-Q · filed 2017-11-08 | $120.36M derived: sum of 2 quarters · filed 2017-11-08 | $176.99M 10-Q · filed 2017-11-08 | $230.84M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-07-02 | $59.76M 10-Q · filed 2017-08-09 | $116.39M 10-Q · filed 2017-08-09 | $170.25M derived: sum of 3 quarters · filed 2018-02-28 | $223.01M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-04-02 | $56.63M 10-Q · filed 2017-05-10 | $110.49M derived: sum of 2 quarters · filed 2018-02-28 | $163.25M derived: sum of 3 quarters · filed 2018-02-28 | $215.75M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-01-02 | $53.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $106.61M derived: sum of 2 quarters · filed 2018-02-28 | $159.12M derived: sum of 3 quarters · filed 2018-02-28 | $209.00M 10-K · filed 2018-02-28 |
| 2015-10-03 | $52.76M 10-Q · filed 2016-11-09 | $105.26M derived: sum of 2 quarters · filed 2016-11-09 | $155.14M 10-Q · filed 2016-11-09 | $206.39M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $52.51M 10-Q · filed 2016-08-09 | $102.38M 10-Q · filed 2016-08-09 | $153.63M derived: sum of 3 quarters · filed 2017-03-01 | $199.13M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $49.88M 10-Q · filed 2016-05-11 | $101.12M derived: sum of 2 quarters · filed 2017-03-01 | $146.62M derived: sum of 3 quarters · filed 2017-03-01 | $189.83M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $51.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $96.75M derived: sum of 2 quarters · filed 2017-03-01 | $139.95M derived: sum of 3 quarters · filed 2017-03-01 | $184.53M 10-K · filed 2017-03-01 |
| 2014-09-27 | $45.50M 10-Q · filed 2015-11-12 | $88.70M derived: sum of 2 quarters · filed 2015-11-12 | $133.28M 10-Q · filed 2015-11-12 | $172.96M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | $43.21M 10-Q · filed 2015-08-12 | $87.78M 10-Q · filed 2015-08-12 | $127.46M derived: sum of 3 quarters · filed 2016-03-01 | $168.61M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-29 | $44.58M 10-Q · filed 2015-05-13 | $84.26M derived: sum of 2 quarters · filed 2016-03-01 | $125.40M derived: sum of 3 quarters · filed 2016-03-01 | $168.38M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-28 | $39.68M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $80.83M derived: sum of 2 quarters · filed 2016-03-01 | $123.80M derived: sum of 3 quarters · filed 2016-03-01 | $166.21M 10-K · filed 2016-03-01 |
| 2013-09-28 | $41.15M 10-Q · filed 2014-11-06 | $84.12M derived: sum of 2 quarters · filed 2014-11-06 | $126.53M 10-Q · filed 2014-11-06 | $165.61M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-06-29 | $42.98M 10-Q · filed 2014-08-05 | $85.38M 10-Q · filed 2014-08-05 | $124.47M derived: sum of 3 quarters · filed 2015-03-17 | $164.81M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-03-30 | $42.40M 10-Q · filed 2014-05-07 | $81.49M derived: sum of 2 quarters · filed 2015-03-17 | $121.83M derived: sum of 3 quarters · filed 2015-03-17 | $158.61M derived: sum of 4 quarters · filed 2015-03-17 |
| 2012-12-29 | $39.09M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $79.43M derived: sum of 2 quarters · filed 2015-03-17 | $116.20M derived: sum of 3 quarters · filed 2015-03-17 | $154.24M 10-K · filed 2015-03-17 |
| 2012-09-29 | $40.34M 10-Q · filed 2013-11-07 | $77.12M derived: sum of 2 quarters · filed 2013-11-07 | $115.15M 10-Q · filed 2013-11-07 | $149.18M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $36.78M 10-Q · filed 2013-08-08 | $74.81M 10-Q · filed 2013-08-08 | $108.83M derived: sum of 3 quarters · filed 2014-03-13 | $142.20M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $38.03M 10-Q · filed 2013-05-07 | $72.06M derived: sum of 2 quarters · filed 2014-03-13 | $105.42M derived: sum of 3 quarters · filed 2014-03-13 | $139.22M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $34.02M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $67.39M derived: sum of 2 quarters · filed 2014-03-13 | $101.19M derived: sum of 3 quarters · filed 2014-03-13 | $137.06M 10-K · filed 2014-03-13 |
| 2011-10-01 | $33.37M 10-Q · filed 2012-11-07 | $67.17M derived: sum of 2 quarters · filed 2012-11-07 | $103.04M 10-Q · filed 2012-11-07 | $136.44M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-07-02 | $33.80M 10-Q · filed 2012-08-08 | $69.67M 10-Q · filed 2012-08-08 | $103.07M derived: sum of 3 quarters · filed 2013-03-11 | $133.82M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-04-02 | $35.87M 10-Q · filed 2012-05-10 | $69.27M derived: sum of 2 quarters · filed 2013-03-11 | $100.02M derived: sum of 3 quarters · filed 2013-03-11 | $129.17M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-01-01 | $33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $64.15M derived: sum of 2 quarters · filed 2013-03-11 | $93.30M derived: sum of 3 quarters · filed 2013-03-11 | $120.76M 10-K · filed 2013-03-11 |
| 2010-10-02 | $30.75M 10-Q · filed 2011-11-09 | $59.90M derived: sum of 2 quarters · filed 2011-11-09 | $87.36M 10-Q · filed 2011-11-09 | |
| 2010-07-03 | $29.15M 10-Q · filed 2011-08-10 | $56.61M 10-Q · filed 2011-08-10 | ||
| 2010-01-02 | $99.98M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |